Author

Angela S. de Ruijter

Institution: Utrecht University

Observed institution: Utrecht University

OpenAlex ID: A5037592549

Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations

2020 · Rick A. Vreman, Angela S. de Ruijter, et al. · Drug Discovery Today · 29

Works count: 1

Citation count: 29

H-index: 1

I10-index: 1